ProShares Ultrashort Health Care (RXD) closed at $11.96 on November 12, 2026, up 1.3% from the previous close, on volume of 43,275 shares (30-day average 16,695).
Data as of November 12, 2026.
12-Nov-2026
No headlines found.
No press releases found.
No news found.
ProShares UltraShort Health Care seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index.
ProShares Ultrashort Health Care trades on the ARCA stock market under the symbol RXD.
As of November 12, 2026, RXD stock price climbed to $11.96 with 43,275 million shares trading.
RXD has a market cap of $2.75 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, RXD traded as high as $28.07 and as low as $11.42.
RXD has underperformed the market in the last year with a price return of -35.8% while the SPY ETF gained +12.0%. RXD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.7% and -8.7%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
RXD support price is $11.42 and resistance is $12.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RXD shares will trade within this expected range on the day.
